Health & Beauty
L’Oreal invests in biotech company Debut
Debut, which is based in San Diego, specialises in the end-to-end discovery, formulation, clinical and manufacture of “novel” ingredients and products
L’Oreal has made a minority investment in US-based biotech company Debut in a bid to scale its manufacturing platform and meet demands for the use of breakthrough ingredients in cosmetics and skincare, The Retail Bulletin has reported.
You'll need to
subscribe to unlock this content. Already subscribed? Login?
